Different biological properties of circulating and bone marrow endothelial progenitor cells in acute myocardial infarction rats

Thoracic and Cardiovascular Surgeon

Volumn 56, Issue 8, 2008, Pages 441-448

  Xin, Z ^a   Meng, Wei ^a   Ya Ping, H ^a   Wei, Z ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute myocardial infarction; Bone marrow; Circulating; Endothelial progenitor cells

Indexed keywords

ANGIOPOIETIN 2; BASIC FIBROBLAST GROWTH FACTOR; FIBRONECTIN; VASCULOTROPIN;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CAPILLARY DENSITY; CELL ADHESION; CELL AGING; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOLOGY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSTHORACIC ECHOCARDIOGRAPHY; Y CHROMOSOME;

ANIMALS; BONE MARROW CELLS; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; FEMALE; FLOW CYTOMETRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; PLURIPOTENT STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION;

EID: 57749110461     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1038879     Document Type: Article

References (33)

1. Krupnick AS, Balsara KR, Kreisel D et al. Fetal liver as a source of autologous progenitor cells for perinatal tissue engineering. Tissue Eng 2004; 10: 723-735
2. Cao Y, Sun Z, Liao L et al. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 2005; 332: 370-379
3. Wu KH, Zhou B, Lu SH et al. In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J Cell Biochem 2007; 100: 608-616
4. Gehling UM, Ergun S, Schumacher U et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106-3112
5. Tatsumi T, Matsubara H. Therapeutic angiogenesis for peripheral arterial disease and ischemic heart disease by autologous bone marrow cells implantation. Nippon Rinsho 2006; 64: 2126-2134
6. Stamm C, Kleine HD, Westphal B et al. CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac Cardiovasc Surg 2004; 52: 152-158
7. Kawamoto A, Asahara T, Losordo DW. Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc Radiat Med 2002; 3: 221-225
8. Le Ricousse-Roussanne S, Barateau V, Contreres JO et al. Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature. Cardiovasc Res 2004; 62: 176-184
9. Madeddu P. Therapeutic angiogenesis and vasculogenesis for tissue regeneration. Exp Physiol 2005; 90: 315-326
10. Rehman J, Li J, Orschell CM et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/ macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164-1169
11. Gu J, Wang CQ, Fan HH et al. Effects of resveratrol on endothelial progenitor cells and their contributions to reendothelialization in intimal-injured rats. J Cardiovasc Pharmacol 2006; 47: 711-721
12. Schachinger V, Assmus B, Honold J et al. Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial. Clin Res Cardiol 2006; 95: 13-22
13. Iwasaki H, Kawamoto A, Ishikawa M et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 2006; 113: 1311-1325
14. Bompais H, Chafraoui J, Canron X et al. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 2004; 103: 2577-2584
15. Hur J, Yoon CH, Kim HS et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004; 24: 288-293
16. Gulati R, Jevremovic D, Peterson TE et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 2003; 93: 1023-1025
17. Massa M, Rosti V, Ferrario M et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005; 105: 199-206
18. Tang J, Xie Q, Pan G et al. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with repeffusion. Eur J Cardiothorac Surg 2006; 30: 353-361
19. Murayama T, Tepper OM, Silver M et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 2002; 30: 967-972
20. Fang NT, Xie SZ, Wang SM et al. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Chin Med J 2007; 120 (8): 696-702
21. Verma S, Kuliszewski MA, Li SH et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004; 109: 2058-2067
22. Matsuo Y, Imanishi T, Hayashi Y et al. The effect of senescence of endothelial progenitor cells on in-stent restenosis in patients undergoing coronary stenting. Intern Med 2006; 45: 581-587
23. De Angelis K, Ogawa T, Sanches IC et al. Impairment of cardiac output and blood flow adjustments to exercise in L-NAME-induced hypertensive rats. J Cardiovasc Pharmacol 2006; 47: 371-376
24. Kawamoto A, Tkebuchava T, Yamaguchi J et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003; 107: 461-468
25. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430-436
26. Kajiguchi M, Kondo T, Izawa H et al. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J 2007; 71: 196-201
27. Murayama T, Tepper OM, Silver M et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hemato 2002; 30: 967-972
28. Cuevas P, Barrios V, Giménez-Gallego G et al. Serum levels of basic fibroblast growth factor in acute myocardial infarction. Eur J Med Res 1997; 28: 282-284
29. Kawamoto A, Kawata H, Akai Y et al. Serum levels of VEGF and basic FGF in the subacute phase of myocardial infarction. Int J Cardiol 1998; 67: 47-54
30. Fontaine V, Filipe C, Werner N et al. Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization. Am J Pathol 2006; 169: 1855-1862
31. Ben-Shoshan J, George J. Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: from experimental models to human trials. Pharmacol Ther 2007; 115: 25-36
32. Cao R, Eriksson A, Kubo H et al. Comparative evaluation of FGF-2-, VEG-F-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 2004; 94: 664-670
33. Satoru N, Hiroshi N, Yoko T, Go W. Protective effect of basic fibroblast growth factor against myocyte death and arrhythmias in acute myocardial infarction in rats. Circ J 2003; 67: 334-339